Julie Willekens

TIM3+<i> TRBV11-2</i> T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste, Lisa Roels, Leslie Naesens et al. · The Journal of Experimental Medicine · 2021 · 84 citations · Full text

Multisystem Inflammatory Syndrome, Adaptive Immune System, Cd16+ Nk Cells +22

Long-Term Prognostic Value of P-Wave Characteristics for the Development of Atrial Fibrillation in Subjects Aged 55 to 74 Years at Baseline

Dirk De Bacquer, Julie Willekens, Guy De Backer · The American Journal of Cardiology · 2007 · 73 citations

Electrophysiological Evaluation, Cardiovascular Disease, Long-term Prognostic Value +5

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

Geert Leroux‐Roels, Cathy Maes, Julie Willekens et al. · Vaccine · 2016 · 66 citations

Vaccination, Maternal Immunization, Preventive Medicine +7

Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials

François Roman, Frédéric Clément, Walthère Dewé et al. · Clinical and Vaccine Immunology · 2011 · 51 citations · Full text

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients

Eef Vanderhelst, Elke De Wachter, Julie Willekens et al. · Journal of Cystic Fibrosis · 2013 · 30 citations · Full text

Antibiotics, Cystic Fibrosis Patients, Healthcare-associated Infection +5